
Alphabet’s life science unit makes device to aid gathering of health data for research
pharmafile | March 11, 2016 | News story | Medical Communications, Research and Development |Â Â Alphabet, Connectivity Bridge, Verily, google, life sciencesÂ
Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for people participating in clinical studies in a filing with the US Securities and Exchange Commission this week.
The wireless hub can be installed in medical facilities and allows data collected with various sensors to be uploaded to the cloud for analysis.
Freshly release photos of the Connectivity Bridge show the device is easily adaptable for use in a home or medical facility. The US Federal Communications Commission approved the Connectivity Bridge last year.
Verily is working in the area of nanodiagnostics, a sort of baseline project that utilizes big data to assimilate all of a person’s genetic and healthcare data. The company is focussing on developing combination products that utilise big data and healthcare. The company is also engaged in researching and developing other biological data monitors.
Drug companies are increasingly looking at tapping into wearable technologies that can collect health-related data to develop new treatments.
Alphabet is the parent company of Google.
Anjali Shukla
Related Content

Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …






